Savitz Adam Insider Trades

Insider Trading History

Track insider trading activity for Savitz Adam. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alto Neuroscience
Alto Neuroscience ANRO
CHIEF MEDICAL OFFICER
Holding Value $3.45M 124,000 shares
Last Trade
Feb 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 124,000 shares
$16.71
$27.80
Alto Neuroscience
Alto Neuroscience ANRO
CHIEF MEDICAL OFFICER
Holding Value $0 0 shares
Last Trade
Jul 03, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$718k 305,653 shares
$2.35
$27.80
Alto Neuroscience
Alto Neuroscience ANRO
CHIEF MEDICAL OFFICER
Holding Value $3.44M 123,645 shares
Last Trade
Jul 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$771k 328,134 shares
$2.35
$27.80
Alto Neuroscience
Alto Neuroscience ANRO
CHIEF MEDICAL OFFICER
Holding Value $2.11M 76,000 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$319k 76,000 shares
$4.20
$27.80
Alto Neuroscience
Alto Neuroscience ANRO
CHIEF MEDICAL OFFICER
Holding Value $1.11M 39,851 shares
Last Trade
Jul 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.7k 2,931 shares
$13.22
$27.80
Alto Neuroscience
Alto Neuroscience ANRO
CHIEF MEDICAL OFFICER
Holding Value $1.03M 36,920 shares
Last Trade
Jul 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$152k 12,069 shares
$12.60
$27.80

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up